Top Big Data Biotechnology Companies in China

Novogene leverages advanced sequencing technologies from top providers, ensuring reliable and high-quality NGS data that is crucial for genomics research. With the largest sequencing capacity globally, Novogene is well-equipped to support big data applications in biotechnology.

BlueGene Biotech is a high-tech company focused on life science and biotechnology, covering research areas such as Cancer, Immunology, and Cell Biology, which are integral to big data applications in biotech research. Their commitment to product development and a global distribution network ensures that they meet the diverse needs of researchers worldwide.

Bio-Gene Technology Limited is a key player in providing innovative instruments and reagents for life sciences and analytical sciences, which can be integral to advancements in big data biotechnology. Their commitment to professional services and solutions enhances the capabilities of laboratories in the scientific community.

LeadArt, a pioneering biotechnology company in China, specializes in advanced chemical proteomics technology and automation, enabling the creation of a comprehensive live cell target-probe database that accelerates drug discovery. Their innovative approach and collaborations with various institutions position them as a key player in expanding the drug target landscape.

Biotheus is dedicated to the discovery and development of novel drugs, particularly for cancer and inflammatory diseases, which may involve the application of big data in biotechnology. Their mission emphasizes innovation and effective drug creation, supported by a robust pipeline of over 20 products in various stages of clinical trials.

Bioworkshops is a specialized biologics contract development and manufacturing organization (CDMO) with extensive experience in applying QbD concepts to enhance the CMC services for late-stage clinical products. Their focus on regulatory affairs and commitment to international GMP compliance positions them as a key player in facilitating the rapid approval of biologic products in major markets like China, the US, and the EU.

Great Bay Bio (GBB) is an innovative biotech company focused on enhancing bioprocessing efficiency through AI and advanced technologies, addressing critical challenges in drug development. With over 30 years of experience, their leadership has established partnerships with leading companies to drive innovation in the biotech sector.

Biocytogen specializes in next-generation antibody drug development, offering integrated solutions and innovative platforms for the discovery and development of fully human monoclonal antibodies and other advanced antibody formats. Their extensive resources, including genetically modified BioMice, support preclinical research and enhance the drug discovery process.

The Laboratory of Data Discovery for Health (D²4H) is focused on gathering and curating massive data resources to develop advanced analytics, particularly in the realms of big data and artificial intelligence. Their work aims to enhance precision medicine and public health through innovative approaches to understanding and treating diseases.

ST-Biotech is a prominent supplier of biological consumable products and services in China, with a strong focus on research and development. Their expertise and capacity for innovation position them as a key player in the biotech industry, particularly in developing high-tech medical products.